Healthtech company Qinec backed by £6m Series B funding
Investment from Gilde Healthcare and Amadeus Capital to help real-time management platform expand in new markets
Digital health start-up Qinec is to expand its patient management platform having secured £6m Series B investment from Gilde Healthcare Partners and existing investors Amadeus Capital Partners and Archimedia.
Based in London, Qinec personalises the delivery of healthcare with its real-time data management platform which optimises outcomes for patients and providers and currently works with “millions” of patients across Europe. Clients include Alliance Medical and Optegra Eye Health Care.
With claims to have achieved an average 100% year-on-year growth, the healthtech start-up now plans to use the the funding to enter new markets and capitalise on an industry with an estimated worth of over $1.3bn.
As part of the deal, Janke Dittmer; partner at Gilde Healthcare, has joined the board as non-executive director alongside Erik Masing as an advisor.
Qinec CEO and founder, Robbie Hughes, said:
“Whilst every clinician would intuitively recognise that healthcare should be a personalised experience, delivering personalisation at scale has been impossible to date with different systems and stakeholders owning different parts of the patient journey. Qinec looks at the problem differently, providing a single platform to join up pathways across specialties and systems, giving visibility and control to providers.”